Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research
about
Utilization of animal models to investigate non-alcoholic steatohepatitis-associated hepatocellular carcinomaConnexins and pannexins in liver damageHow Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?Fat content, fatty acid pattern and iron content in livers of turkeys with hepatic lipidosis.High fat plus high cholesterol diet lead to hepatic steatosis in zebrafish larvae: a novel model for screening anti-hepatic steatosis drugs.In Situ Evaluation of Oxidative Stress in Rat Fatty Liver Induced by a Methionine- and Choline-Deficient DietTopological and functional analysis of nonalcoholic steatohepatitis through protein interaction mapping.Tissue Engineering Approaches in the Design of Healthy and Pathological In Vitro Tissue Models.Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice.Connexins and their channels in inflammation.Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease.Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems.Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice.Connexin32 deficiency is associated with liver injury, inflammation and oxidative stress in experimental non-alcoholic steatohepatitis.Tools to Measure Cell Health and Cytotoxicity Using High Content Imaging and Analysis.Niga-ichigoside F1 ameliorates high-fat diet-induced hepatic steatosis in male mice by Nrf2 activation.Antidiabetic and Lipid-Lowering Effects of the Polyphenol Extracts from the Leaves of Clausena lansium (Lour.) Skeels on Streptozotocin-Induced Type 2 Diabetic Rats.Metabolic profiling of ob/ob mouse fatty liver using HR-MAS 1H-NMR combined with gene expression analysis reveals alterations in betaine metabolism and the transsulfuration pathway.Using zebrafish to model liver diseases-Where do we stand?High-fat diet inhibits PGC-1α suppressive effect on NFκB signaling in hepatocytes.Ethanol extract of Allium fistulosum inhibits development of non-alcoholic fatty liver disease.Quantitative Assessment of Liver Steatosis and Affected Pathways with Molecular Imaging and Proteomic Profiling.Clinical application of angiotensin receptor blockers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.Current status of imaging in nonalcoholic fatty liver diseaseSystems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of Jiang Zhi Granule on non-alcoholic fatty liver disease
P2860
Q26748807-CFD5479F-456F-472D-B591-5DB6D0F1662AQ26750050-F26A818A-3227-4478-BD5D-5277CB54A85CQ28074455-6D259DEB-1146-416B-906D-39169420250DQ33743274-80969E0E-A692-464B-85D3-3138032C3AB6Q36292759-475B8F4F-259A-45B8-8974-CB42343CAA90Q36531596-23747D9C-28EE-4AAB-A5E1-D766B85D354FQ37643647-0A5BFEC7-4872-44EF-A82F-FB330302EAE8Q38644027-9B5C0C80-D4F8-4B8D-89C0-C11265193AFCQ38786112-45F65318-1F61-4E75-B7CE-6A2D72262304Q38888995-155DDFD8-D1A7-4A09-9F86-FF643CC60D6AQ39140524-773FD2E8-64B5-4AA0-BD17-A07FB53DFF55Q39306694-64C0A342-0BD4-4962-A888-45FDDC5F571BQ41419929-CBAFCA1B-3129-4A9C-B45A-1CFF61E98006Q43635935-3F895906-A421-46A9-A930-2C6322824365Q46272510-403FA9B7-60BD-41BF-BC24-F522F48D43E3Q47194703-100AD166-08F9-42D0-AA99-35A437BDDD9DQ47262151-DEAD18AC-7D54-4654-AE26-4E913B4D9269Q50115683-C74D0856-5E65-4CB4-A239-8966F368C9CDQ50425163-3F190DE0-4938-46D1-9F9E-5A7F809A383AQ50625684-35D18F4C-AA32-4BB3-B013-0E4360AD97EDQ52599636-A6BA6C49-8710-4F12-9A99-6FC9EA5DDE76Q52730229-414638C5-FF7F-4066-B546-43F103C253D8Q55008612-67003566-E249-4FDD-87C3-BDA8A8D223C2Q58700636-E37647D8-620B-448A-84DC-A8221B223FD2Q58747347-65211B4C-5EB5-402D-A4BF-224899CF4235
P2860
Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Strategies, models and biomark ...... c fatty liver disease research
@ast
Strategies, models and biomark ...... c fatty liver disease research
@en
type
label
Strategies, models and biomark ...... c fatty liver disease research
@ast
Strategies, models and biomark ...... c fatty liver disease research
@en
prefLabel
Strategies, models and biomark ...... c fatty liver disease research
@ast
Strategies, models and biomark ...... c fatty liver disease research
@en
P2093
P2860
P50
P1476
Strategies, models and biomark ...... c fatty liver disease research
@en
P2093
Bert Van Den Bossche
Cláudia Pinto Marques Souza de Oliveira
Isabel Veloso Alves Pereira
Isabelle Colle
Tereza Cristina Da Silva
Venâncio Avancini Alves
P2860
P304
P356
10.1016/J.PLIPRES.2015.05.002
P577
2015-06-11T00:00:00Z